The broad interest in MHC-derived MS relies on its ability to discover MHC presented peptides in real scenarios, such as biomarker discovery in cancer, autoimmune and infectious disease, and therefore identifying peptides that might induce T cell responses. Here, HLA-C is linked to infectious disease.